Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

High-dose ISIS-2302 enemas improve symptoms in ulcerative colitis

Oct. 15, 2001

Gene therapy with IL-10 produces therapeutic benefit in experimental colitis

Oct. 15, 2001

Inhibition of p38 MAPK in experimental model of colitis has dual effect

Oct. 15, 2001

Efficacy of MAP kinase blocker CNI-1493 in Crohn's disease seen in pilot trial

Oct. 15, 2001

Roche's PEGASYS introduced in first market

Oct. 15, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Phase II trial of Heptazyme for hepatitis C initiated

Oct. 11, 2001

New triple therapy for H. pylori eradication submitted for approval on two fronts

Oct. 9, 2001

InKine expands marketing effort for oral purgative preparation to Europe

Oct. 9, 2001

Forty-eight-week results support efficacy of adefovir dipivoxil in HBV/HIV-coinfected subjects

Oct. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...